8-Year follow-up of randomized trial: Cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer

Annals of Surgical Oncology

Volumn 15, Issue 9, 2008, Pages 2426-2432

  Verwaal, Vic J ^a   Bruin, Sjoerd ^a   Boot, Henk ^a   Van Slooten, Gooike ^a   Van Tinteren, Harm ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Colorectal cancer; Cytoreduction; HIPEC; Peritoneal carcinomatosis; Randomized trial

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MITOMYCIN C;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOREDUCTION; FEMALE; HUMAN; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; SURGICAL TECHNIQUE; SURVIVAL TIME; TUMOR GROWTH;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; HYPERTHERMIA, INDUCED; INJECTIONS, INTRAPERITONEAL; LAPAROTOMY; LEUCOVORIN; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PERITONEAL NEOPLASMS; PROGNOSIS; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; X-RAYS;

EID: 50049095308     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-9966-2     Document Type: Article

References (26)

1. O Glehen D Osinsky AC Beaujard 2003 Natural history of peritoneal carcinomatosis from nongynecologic malignancies Surg Oncol Clin N Am 12 729 39, xiii
2. DG Jayne S Fook C Loi 2002 Peritoneal carcinomatosis from colorectal cancer Br J Surg 89 1545 50
3. PH Sugarbaker 1994 Intraperitoneal chemotherapy for treatment and prevention of peritoneal carcinomatosis and sarcomatosis Dis Colon Rectum 37 S115 22
4. PH Sugarbaker 1999 Management of peritoneal-surface malignancy: the surgeon's role Langenbecks Arch Surg 384 576 87
5. RJ Troisi AN Freedman SS Devesa 1999 Incidence of colorectal carcinoma in the U.S.: an update of trends by gender, race, age, subsite, and stage, 1975-1994 Cancer 85 1670 6
6. TD Yan F Chu M Links 2006 Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma: non-mucinous tumour associated with an improved survival Eur J Surg Oncol 32 1119 24
7. PH Sugarbaker 2005 A curative approach to peritoneal carcinomatosis from colorectal cancer Semin Oncol 32 S68 73
8. PH Sugarbaker 2007 Peritonectomy procedures Cancer Treat Res 134 247 64
9. JS Spratt RA Adcock W Sherrill 1980 Hyperthermic peritoneal perfusion system in canines Cancer Res 40 253 5
10. O Glehen F Kwiatkowski PH Sugarbaker 2004 Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study J Clin Oncol 22 3284 92
11. AL Bloemendaal VJ Verwaal S van Ruth 2005 Conventional surgery and systemic chemotherapy for peritoneal carcinomatosis of colorectal origin: a prospective study Eur J Surg Oncol 31 1145 51
12. B Sadeghi C Arvieux O Glehen 2000 Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study Cancer 88 358 63
13. VJ Verwaal S van Ruth E de Bree 2003 Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer J Clin Oncol 21 3737 43
14. AJ Witkamp E de Bree R Van Goethem 2001 Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy Cancer Treat Rev 27 365 74
15. S Gill RR Thomas RM Goldberg 2003 Review article: colorectal cancer chemotherapy Aliment Pharmacol Ther 18 83 692
16. A de Gramont A Figer M Seymour 2000 Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer J Clin Oncol 18 2938 47
17. J Tabernero E Van Cutsem E Diaz-Rubio 2007 Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer J Clin Oncol 25 5225 32
18. H Hurwitz L Fehrenbacher W Novotny 2004 Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N Engl J Med 350 2335 42
19. E de Bree W Koops R Kroger 2004 Peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement J Surg Oncol 86 64 73
20. G Folprecht CH Kohne MP Lutz 2007 Systemic chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer Cancer Treat Res 134 425 40
21. F Baulieu P Bourlier B Scotto 2001 The value of immunoscintigraphy in the detection of recurrent colorectal cancer Nucl Med Commun 22 1295 304
22. VJ Verwaal S van Ruth A Witkamp 2005 Long-term survival of peritoneal carcinomatosis of colorectal origin Ann Surg Oncol 12 65 71
23. VJ Verwaal H van Tinteren S van Ruth 2004 Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy Br J Surg 91 739 46
24. VJ Verwaal H van Tinteren van Ruth 2004 Toxicity of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy J Surg Oncol 85 61 7
25. RM Smeenk VJ Verwaal FA Zoetmulder 2007 Learning curve of combined modality treatment in peritoneal surface disease Br J Surg 94 1408 14
26. J Esquivel R Sticca P Sugarbaker 2007 Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology Ann Surg Oncol 14 128 33